Want to see RVP full AI Analyst Report?
Retractable Technologies (RVP) AI Stock Analysis
Retractable Technologies
(NYSE MKT:RVP)
The overall score reflects weak core financial performance driven by structurally lower post-2021 revenues, compressed margins, and largely negative cash flows, only partly mitigated by a conservative, low-leverage balance sheet that reduces solvency risk. Neutral technicals and a loss-making valuation with no common dividend provide neither strong support nor clear downside signals, while the recent preferred dividend declaration is a modest positive that shows some confidence and discipline but does not fundamentally change the risk-return profile for common shareholders.
Retractable Technologies (RVP) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $16.94M
- Dividend Yield
- ―
- Average Volume (3M)
- 32.03K
- Price to Earnings (P/E)
- -4.7
- Beta (1Y)
- 0.50
- Revenue Growth
- -11.16%
- EPS Growth
- 59.85%
- Country
- US
- Employees
- 198
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
Retractable Technologies Business Overview & Revenue Model
Company Description
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader Nor...
Retractable Technologies Financial Statement Overview
Summary
Financial performance is weak overall, with revenue materially below the 2021 peak, compressed margins, and sustained operating losses, compounded by volatile and mostly negative cash flow since 2022. The main offsetting strength is a conservatively financed balance sheet with low leverage and meaningful equity cushion, which limits financial risk but does not yet translate into attractive returns.
Income Statement
30NegativeBalance Sheet
55NeutralCash Flow
28Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.90M | 38.27M | 33.05M | 43.60M | 94.82M | 188.38M |
| Gross Profit | 371.53K | 47.05K | -1.03M | 9.11M | 28.25M | 95.35M |
| EBITDA | 4.53M | -4.42M | 4.17M | -1.24M | 9.94M | 76.44M |
| Net Income | -3.37M | -12.57M | -11.89M | -7.01M | 5.08M | 56.06M |
Balance Sheet | ||||||
| Total Assets | 141.69M | 142.63M | 160.72M | 179.67M | 210.74M | 213.15M |
| Cash, Cash Equivalents and Short-Term Investments | 39.87M | 36.97M | 44.56M | 47.29M | 49.38M | 42.43M |
| Total Debt | 715.92K | 895.64K | 1.23M | 1.54M | 2.92M | 4.24M |
| Total Liabilities | 68.83M | 68.26M | 73.55M | 80.38M | 104.21M | 113.98M |
| Stockholders Equity | 72.87M | 74.38M | 87.17M | 99.29M | 106.54M | 99.17M |
Cash Flow | ||||||
| Free Cash Flow | -5.11M | -7.60M | -13.00M | 1.91M | -61.95K | -25.57M |
| Operating Cash Flow | -4.96M | -7.06M | -11.56M | 2.77M | 16.77M | 32.79M |
| Investing Cash Flow | 5.18M | 5.98M | 3.66M | -10.76M | -31.20M | -63.04M |
| Financing Cash Flow | -632.04K | -567.32K | -535.43K | 941.64K | 4.99M | 41.84M |
Retractable Technologies Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RVP, the sentiment is Negative. The current price of 0.57 is below the 20-day moving average (MA) of 0.59, below the 50-day MA of 0.66, and below the 200-day MA of 0.68, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 31.86 is Neutral, neither overbought nor oversold. The STOCH value of 15.40 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RVP.
Retractable Technologies Risk Analysis
Retractable Technologies disclosed 18 risk factors in its most recent earnings report. Retractable Technologies reported the most risks in the "Macro & Political" category.
Latest Risks Added
0 New RisksRetractable Technologies Peers Comparison
Overall Rating
OSUR54Neutral
MLSS51Neutral- RVP48Neutral
SMTI46Neutral
STXS45Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| OSUR | 54Neutral | $256.56M | -4.88 | -14.73% | ― | -18.86% | -0.63% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| MLSS | 51Neutral | $29.82M | -6.27 | -149.08% | ― | 3.72% | 43.78% |
| RVP | 48Neutral | $16.94M | -4.70 | -4.59% | ― | -11.16% | 59.85% |
| SMTI | 46Neutral | $297.05M | -8.50 | -473.55% | ― | 12.93% | -219.19% |
| STXS | 45Neutral | $95.91M | -4.25 | -132.62% | ― | -5.47% | 13.55% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RVP | Retractable Technologies | 0.57 | -0.25 | -30.98% | |
| OSUR | Orasure | 3.37 | 0.98 | 40.71% | |
| STXS | Stereotaxis | 1.05 | -1.67 | -61.40% | |
| MLSS | Milestone Scientific Inc | 0.30 | -0.10 | -25.06% | |
| SMTI | Sanara MedTech | 31.61 | 3.89 | 14.03% |
Retractable Technologies Corporate Events
Retractable Technologies Declares Dividend on Preferred Shares
PositiveOn September 30, 2026, Retractable Technologies announced it had declared a dividend for holders of its Series II and Series III Class B Convertible Preferred Stock. The move highlights the company’s capital allocation to preferred shareholders...
Retractable Technologies Reports Latest Quarterly Financial Results
NeutralOn August 14, 2026, Retractable Technologies announced its financial results for the periods ended June 30, 2026. The release of these results provides stakeholders with updated visibility into the company’s recent operating performance and may...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 30, 2026